New Research Links Overtraining Syndrome to Elevated PARP1 Protein in Skeletal Muscles

Excessive physical training without adequate rest can significantly harm the body, with severe cases leading to overtraining syndrome. This condition manifests through decreased athletic performance, persistent fatigue, muscle pain, increased injury risk, and alterations in immune function and metabolism. A recent study published in the journal Molecular Metabolism reveals that overtraining may be driven by the overexpression of the PARP1 protein in muscles.

Researchers from the State University of Campinas's School of Applied Sciences (FCA-UNICAMP) in Limeira, Brazil, conducted experiments on mice subjected to intense treadmill training that mimics overtraining. They observed that these mice experienced performance decline, fatigue, and behavioral changes, such as increased inactivity and self-cleaning behaviors. Notably, these symptoms correlated with heightened levels of PARP1 in skeletal muscles.

PARP1, an enzyme activated under stress conditions to prevent cell death, is known to be involved in obesity and muscular dystrophies when hyperactivated. Dr. Barbara Crisol, lead researcher, explained that their findings confirm a link between exaggerated PARP1 activity and muscle damage from excessive exercise. The study also tested a drug that inhibits PARP1 activity, which prevented performance decline and symptoms in mice, suggesting a potential therapeutic approach.

While olaparib, a PARP1 inhibitor used in cancer treatments, can counteract overtraining effects in animals, it comes with drawbacks like immune suppression. Therefore, the researchers are seeking natural compounds that can reduce PARP1 activity in muscles without adverse effects.

Additional human studies conducted at the Swedish School of Sport and Health Sciences involved volunteers undergoing a three-week high-intensity interval training (HIIT) protocol designed to simulate overtraining. Muscle biopsies revealed that this protocol impaired glucose tolerance, mitochondrial function, and physical performance, consistent with findings in mice.

Crisol noted that excessive exercise increases muscle PARP1 activity, which may lead to muscle paralysis, similar to what is observed in muscular dystrophies and other conditions involving muscle degradation. Since PARP1 is linked to various muscle-related diseases, finding safe inhibitors could have broad therapeutic implications.

This research emphasizes the importance of balanced training and highlights potential pharmacological targets for preventing or treating overtraining syndrome, benefitting both athletes and the general population.